Silencing of FOXM1 transcription factor expression by adenovirus-mediated RNA interference inhibits human hepatocellular carcinoma growth
Authors:
- 28 February 2014
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 21 (3) , 133-138
Abstract
The Forkhead Box M1 (FOXM1) transcription factor has been considered as a potential target for the prevention and/or therapeutic intervention in human carcinomas because of its roles in tumorigenesis and tumor progression through regulating the expression of genes relevant to cell proliferation and transformation. In this study, FOXM1 was found to express strongly in both clinical tissue specimens and human hepatocellular carcinoma (HCC) cell lines such as Huh-6, Huh-7 and HepG2. The knockdown of FOXM1 expression through an adenovirus vector (named AdFOXM1shRNA), which expresses a short hairpin RNA to downregulate FOXM1 expression specifically, diminished the proliferation of Huh-7 and HepG2 cells and anchorage-independent growth of Huh-7 cells. Furthermore, we assessed the efficacy of AdFOXM1shRNA for tumor gene therapy with the Huh-7 cell xenograft mouse model and found that the tumor growth was significantly suppressed when inoculated mice were injected with AdFOXM1shRNA in the tumors. Together, our results suggest that FOXM1 is a potential therapeutic target for HCC and AdFOXM1shRNA may be an additional gene therapeutic intervention for HCC treatment.Keywords
This publication has 55 references indexed in Scilit:
- FoxM1: A Master Regulator of Tumor MetastasisCancer Research, 2011
- Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivoJournal of Experimental & Clinical Cancer Research, 2010
- Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cellsNucleic Acids Research, 2010
- Forkhead box M1 transcription factor: A novel target for cancer therapyCancer Treatment Reviews, 2010
- Adenovirus receptors and their implications in gene deliveryVirus Research, 2009
- FOXM1 Upregulation Is an Early Event in Human Squamous Cell Carcinoma and it Is Enhanced by Nicotine during Malignant TransformationPLOS ONE, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- FoxM1c Counteracts Oxidative Stress-induced Senescence and Stimulates Bmi-1 ExpressionJournal of Biological Chemistry, 2008
- Prognostic molecular markers in hepatocellular carcinoma: A systematic reviewEuropean Journal of Cancer, 2007
- Chk2 Mediates Stabilization of the FoxM1 Transcription Factor To Stimulate Expression of DNA Repair GenesMolecular and Cellular Biology, 2007